Skip to content
Screener

Relay Therapeutics, Inc. RLAY Prepaid & Other Current

Prepaid & Other Current at other companies

Schrodinger logo
SchrodingerSDGR
$10.55M-29.4%
PVL
Palvella TherapeuticsPVLA
$1.38M-24.9%
Recursion Pharmaceuticals, Inc. logo
Recursion Pharmaceuticals, Inc.RXRX
$8.68M
Revolution Medicines, Inc. logo
Revolution Medicines, Inc.RVMD
$90.37M+130%
Immunome logo
ImmunomeIMNM
$11.62M+100%
Cogent Biosciences, Inc. logo
Cogent Biosciences, Inc.COGT
$12.52M+74.9%

Other financials

Income statement

See full
Revenue$350.0K-48.3%
Operating income-$90.8M-18.2%
Net income-$83.7M-18.9%
EPS (diluted)-$0.410.0%

Balance sheet

See full
Cash & equivalents$121.2M+6.4%
Total debt$30.7M-10.3%
Total equity$890.0M+33.7%
Total assets$967.5M+32.7%

Cash flow

See full
Operating cash flow-$54.1M+2.1%
CapEx$1.0K
Free cash flow-$44.9M+22.5%

Valuation

See full
Market cap$4.33B+673%
Enterprise value$4.24B+783%
P/S418.6×+352×

Profitability

See full
Operating margin-2,999.4%-637pp
Net margin-2,763.6%-568pp
FCF margin-1,536%-429pp

Returns & leverage

See full
Return on equity-36.8%-6.3pp
Debt / equity0.0×
Current ratio18.3×-2.7×

Where this comes from

Reported directly by Relay Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:PrepaidExpenseCurrent.

The source filing: Relay Therapeutics, Inc.’s 10-Q, filed August 6, 2026.

Filed
Aug 6, 2026, 4:15 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001193125-26-338056
Line itemJune 30, 2026December 31, 2025
Current assets:
Cash and cash equivalents$121,189$84,018
Investments789,745470,500
Prepaid expenses8,73517,787
Other current assets8,4135,974
Total current assets928,082578,279
Property and equipment, net8621,726
Operating lease assets37,17739,990

Item 1. Financial Statements.

FAQ

What is Relay Therapeutics, Inc.'s prepaid & other current?
Relay Therapeutics, Inc. (RLAY) reported prepaid & other current of $8.74M in Q2 2026.
How has Relay Therapeutics, Inc.'s prepaid & other current changed year-over-year?
Relay Therapeutics, Inc.'s prepaid & other current decreased by 45.5% year-over-year, from $16.04M to $8.74M.
What is the long-term trend for Relay Therapeutics, Inc.'s prepaid & other current?
Over 5 years (2020 to 2025), Relay Therapeutics, Inc.'s prepaid & other current has grown at a 13.6% compound annual growth rate (CAGR), from $9.39M to $17.79M.
What does prepaid & other current mean?
Advance payments for expenses (rent, insurance, subscriptions) plus miscellaneous current assets not classified elsewhere.

Ask your AI about Relay Therapeutics, Inc.'s prepaid & other current.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude